Afatinib Impurity 48(CAS: 162012-69-3)

Afatinib Impurity 48 (CAS: 162012-69-3) is a byproduct or contaminant identified during the synthesis of Afatinib, a kinase inhibitor used in cancer treatment. It is typically analyzed in pharmaceutical quality control to ensure drug purity. The compound's chemical structure and properties are closely related to Afatinib but may vary slightly, making it critical for regulatory compliance and safety testing in drug development.

Afatinib Impurity 48 (CAS: 162012-69-3) is primarily used in pharmaceutical research and quality control to assess the purity of Afatinib. It also aids in understanding degradation pathways during drug stability testing. Additionally, it serves as a reference standard in analytical methods to identify impurities in drug manufacturing processes.

Afatinib Impurity 48 (CAS: 162012-69-3) is not intended for human or animal use and should be handled with care. Safety data indicates potential toxicity upon prolonged exposure, necessitating proper protective equipment and ventilation. It is crucial to follow established safety protocols to minimize risks during laboratory handling and storage.

Afatinib Impurity 48 (CAS: 162012-69-3) should be stored in a sealed, light-resistant container at controlled room temperature (15-25°C) or refrigerated conditions (2-8°C) to maintain stability. Keep it away from moisture and heat sources. Proper storage ensures minimal degradation and adherence to safety standards for handling and use.